Louis O’Dea

Lipoprotein(a) Reduction in Persons with Cardiovascular Disease

Sotirios Tsimikas, Ewa Karwatowska‐Prokopczuk, Ioanna Gouni‐Berthold et al. · New England Journal of Medicine · 2020 · 1K citations · Full text

Life Sciences, Genetics, Pharmacotherapy +17

Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome

Joseph L. Witztum, Daniel Gaudet, Steven D. Freedman et al. · New England Journal of Medicine · 2019 · 669 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

Vupanorsen, an N-acetyl galactosamine-conjugated antisense drug to <i>ANGPTL3</i> mRNA, lowers triglycerides and atherogenic lipoproteins in patients with diabetes, hepatic steatosis, and hypertriglyceridaemia

Daniel Gaudet, Ewa Karwatowska‐Prokopczuk, Seth J. Baum et al. · European Heart Journal · 2020 · 277 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Sex Steroid Control of Gonadotropin Secretion in the Human Male. I. Effects of Testosterone Administration in Normal and Gonadotropin-Releasing Hormone-Deficient Men*

Joel S. Finkelstein, Randall W. Whitcomb, Louis O’Dea et al. · The Journal of Clinical Endocrinology & Metabolism · 1991 · 267 citations

Medicine, Endocrinology, Reproductive Endocrinology +16

Effects of Abaloparatide, a Human Parathyroid Hormone-Related Peptide Analog, on Bone Mineral Density in Postmenopausal Women with Osteoporosis

Benjamin Z. Leder, Louis O’Dea, José Zanchetta et al. · The Journal of Clinical Endocrinology & Metabolism · 2014 · 260 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17